Passage Bio, Inc. Share Price

Passage Bio, Inc. Share Price

NASDAQ: PASG | Micro Cap
$4.17
+$0.19 (4.91%) Last updated on 18 Nov, 2026 | 02:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Passage Bio, Inc. Stock Performance

Open
$4.22
Prev. Close
$3.98
Circuit Range
N/A
Day Range
$4.22 - $4.22
Year Range
$3.33 - $19.81
Volume
829
Average Traded
$4.22

Passage Bio, Inc. Share Price Today

As of 18 November 2026, Passage Bio, Inc.'s share price is $4.17. The stock opened at $4.22, compared to its previous close of $3.98. During today's trading session, Passage Bio, Inc.'s share price traded between $4.22 and $4.22, with an average price of $4.22. Over the past 52 weeks, the stock has recorded a high of $19.81 and a low of $3.33. In terms of performance, Passage Bio, Inc.'s share price has declined by 26.84% over the last six months and is down 51.82% on a year-on-year basis.

Passage Bio, Inc. Share Price Chart

Line chart of the Passage Bio, Inc. price trend over the selected period. The price rose overall, ranging from 3.81 to 4.22, ending at 4.17.
$4.22$4.22
L
Show Current Price
H

Passage Bio, Inc. Stock Fundamentals & Key Indicators

Market Cap
$13.23M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-10.28
Revenue (TTM)
$0.00
Return On Equity (TTM)
-66164.00%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
63.64%

Passage Bio, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$12.98-$7.56-$7.82-$4.72
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A41.76%-3.44%39.64%

Passage Bio, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$136.13-$102.06-$64.77-$45.52
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A25.03%36.54%29.72%

About Passage Bio, Inc.

Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.

Passage Bio, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$3.55
$4.22
+12.67%
Oct 2026
$4.34
$3.75
-17.04%
Sep 2026
$4.71
$4.52
+1.12%
Aug 2026
$4.68
$4.47
+0.00%
Jul 2026
$4.92
$4.47
-8.21%
Jun 2026
$5.80
$4.87
-14.56%
May 2026
$5.00
$5.70
+14.23%
Apr 2026
$7.64
$4.99
-31.55%
Mar 2026
$8.63
$7.29
-19.71%
Feb 2026
$12.18
$9.08
-20.97%
Jan 2026
$11.82
$11.49
-1.37%
Dec 2025
$8.03
$11.65
+34.60%

PASG Share Price FAQs